Skip to content

Artikaiini 40mg ja kloroprokaiini 40 mg päiväkirurgisina spinaalipuudutteina (Lyhenne: A40C40) - A40C40

Artikaiini 40mg ja kloroprokaiini 40 mg päiväkirurgisina spinaalipuudutteina (Lyhenne: A40C40) - A40C40

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-000062-35-FI
Enrollment
Unknown
Registered
2011-01-18
Start date
2011-04-05
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee arthroscopy performed as day case surgery MedDRA version: 12.1 Level: LLT Classification code 10054948 Term: Meniscus operation

Interventions

Trade Name: Ultracain D ohne Adrenalin 40 mg/ml, Aventis Pharmaceutical Form: Solution for injection INN or Proposed INN: ARTICAINE HYDROCHLORIDE CAS Number: 23964570 Concentration unit: mg/ml milligr

Sponsors

Mikko Pitkänen, MD, PhD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age 18 - 70 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Body mass index > 36 kg/m2

Design outcomes

Primary

MeasureTime frame
Main Objective: The purpose of the study is to compare singel doses of articaine 40 mg and chloroprocaine 40 mg as spinal anesthetics in patients scheduled for ambulatory knee arthroscopy. The null hypothesis is that there will be reliable and sufficient spinal anesthesia in both study groups combined with no differences between the study groups as regards recovery from spinal anesthesia (main outcome parameter: recovery from motor blockade).;Secondary Objective: ;Primary end point(s): Recovery from spinal anesthesia (particularly from motor blockade)

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026